Search PubMed⌕ Search

Biomedical subjects

M Dy

Publications and source records attributed to M Dy.

At least 73 records · Page 4Linked to original sources

[Effects of hematopoietic growth factor (GM-CSF: granulocyte-macrophage colony-stimulating factor) on thymocyte proliferation induced by interleukin-1 (IL-1)].

A semi-purified fraction obtained from P388 D1 cell line conditioned medium (P388 D1 CM) which contains Interleukin-1 (IL-1) and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) stimulates murine thymocyte proliferation both in the absence and the presence of a suboptimal dose of phytohemagglutinin (PHA). Because this effect on thymocyte proliferation is always larger than that obtained with optimal concentrations of pure IL-1, we have investigated the possible involvement of GM-CSF in this semi-purified fraction mediated-thymocyte proliferation. We here show that the maximal level of thymocyte proliferation induced by the semi-purified fraction is comparable to that obtained by the co-addition of recombinant GM-CSF and IL-1. In addition, although GM-CSF alone induces no significant thymocyte proliferation, the presence of an anti-GM-CSF antiserum partially blocks the thymocyte proliferation induced by the semi-purified fraction. Thus, the capacity of the semi-purified fraction of P388 D1 to stimulate thymocyte proliferation appears to result from a synergistic action between GM-CSF and IL-1.

Animals↗

Superoxide-induced deimination of arginine in hematopoietic cells.

Murine bone marrow cells can produce citrulline directly from L-arginine without intermediate ornithine. An L-arginine-dependent biochemical pathway synthesizing L-citrulline and nitrate, coupled to an effector mechanism has also been recently demonstrated in murine cytotoxic activated macrophages. We show herein that L-citrulline synthesis in murine bone marrow cells can be induced by the generation of superoxide. It can take place in an arginine-free medium, suggesting the implication of a superoxide-dependent peptidyl arginine deiminase.

Animals↗

Histamine-producing cell-stimulating activity. Interleukin 3 and granulocyte-macrophage colony-stimulating factor induce de novo synthesis of histidine decarboxylase in hemopoietic progenitor cells.

Both interleukin 3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) induce increased histamine production by murine hemopoietic cells. Histidine-free culture conditions or addition of alpha-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, completely abrogate this phenomenon, indicating that increased histamine levels result from an augmentation of the rate of its synthesis. L-Histidine decarboxylase (HDC) (EC 4.1.1.22) activity is detected in normal bone marrow cell lysates. It is markedly increased following incubation of the cells with IL-3 or GM-CSF. The cells responding by the most important enhancement of HDC activity are located in the less dense layers of a discontinuous Ficoll gradient containing the majority of the hemopoietic progenitor cell types, such as colony-forming units (spleen), granulocyte-macrophage colony-forming cells, and mast cell precursors. In comparison with other HDC-containing cell populations tested, the enzymatic activity contained in these cells is particularly high after IL-3 or GM-CSF treatment and similar to the HDC levels observed in murine fetal liver. The time course of IL-3 and GM-CSF-induced HDC activation at comparable concentrations is slightly different. In response to GM-CSF, HDC activation is more rapid, with a significant enhancement after 4 hr of incubation, as compared with IL-3-induced HDC activation. Moreover, in the latter case the activation increases more progressively up to 48 hr of incubation, whereas GM-CSF-induced increase of HDC activity reaches a plateau more rapidly. In addition, maximal increase in histamine production in response to IL-3 is always higher than in response to GM-CSF. Moreover, the simultaneous presence of both factors at optimal concentration induces only a partially cumulative effect. These results suggest that IL-3 and GM-CSF induce HDC activation in two distinct ways, possibly reflecting the involvement of distinct target cells. However, both mediators act by inducing the transcription of the HDC gene and de novo synthesis of this enzyme since actinomycin D or cycloheximide abolish GM-CSF-or IL-3-induced histamine-producing cell-stimulating activity. This synthesis is independent from cell proliferation as demonstrated by the lack of effect of bone marrow cell irradiation. Finally, the observation that cholera toxin, prostaglandin E2, and N6,2'-O-dibutyryl adenosine 3',5'-cyclic monophosphate mimic the effects of IL-3 and GM-CSF on bone marrow cell HDC suggests an involvement of cyclic adenosine monophosphate in factor-induced histamine-producing cell-stimulating activity.

Animals↗

A new enzymatic pathway of citrullinogenesis in murine hemopoietic cells.

Citrullinogenesis is demonstrated when murine bone marrow cells are incubated with dialyzed secondary mixed leukocyte culture supernatant. The identity of citrulline in bone marrow cell supernatants has been established by gas chromatographic mass spectrometric analysis. It is shown that, in our model, citrulline synthesis proceeds directly from arginine without intermediate ornithine production, ruling out the involvement of ornithine transcarbamylase (EC 2.1.3.3.). Moreover, none of the other enzymatic activities described for catalyzing citrullinogenesis, i.e. arginine deiminase or peptidyl arginine deiminase can be demonstrated. The generation of oxygen radicals is necessary for this enzymatic reaction. It is induced by a thermolabile protein produced during the antiallograft immune response with a molecular weight of about 150,000.

Animals↗

Histamine-producing cell-stimulating activity. A biological activity shared by interleukin 3 and granulocyte-macrophage colony-stimulating factor.

The histamine-producing cell-stimulating factor (HCSF) was first described as a lymphokine which is produced during secondary mixed leukocyte culture and which induces increased histamine synthesis by murine hematopoietic cells. It has been shown that it is different from interleukin 3 (IL 3), despite the fact that pure IL 3 expresses HCSF activity. Our results provide evidence that this factor (constitutively produced by the P388 D1 cell line) is identical with granulocyte-macrophage colony-stimulating factor (GM-CSF) i.e.: (a) physiochemical properties of HCSF and GM-CSF, such as molecular weight, isoelectric charge, hydrophobicity and behavior during affinity chromatography, are indistinguishable and both activities coelute during all biochemical purification procedures; (b) increased bone marrow cell histamine synthesis induced by P388 D1-derived HCSF is inhibited by anti-GM-CSF antiserum; (c) the GM-CSF cDNA probe hybridizes with a poly(A)+RNA from P388 D1 cells while no hybridizing signal was obtained with poly(A)+RNA from WEHI-3 and from P815 cells. On the other hand, the IL 3 cDNA probe hybridizes with a 1.0-kb poly(A)+RNA from WEHI-3 but not with those from P388 D1 and P815. Moreover, well known sources of GM-CSF, such as lung conditioned medium and semi-purified GM-CSF from phytohemagglutinin-induced supernatant of the murine T lymphoma LBRM-33-5 A4 (preparation devoid of IL 3), as well as recombinant murine GM-CSF, induce increased histamine synthesis by hematopoietic cells. All these results demonstrate that, in our culture conditions, the P388 D1 cell line spontaneously produces GM-CSF which is responsible for the P388 D1-induced HCS activity. Consequently, the latter is a property shared by the two distinct hematopoietic growth factors acting on the less committed cells, i.e. IL 3 and GM-CSF, whereas M-CSF or G-CSF are unable to induce histamine production. Interestingly, IL-4 which is known to support established mast cell line proliferation cannot induce HCS activity. In addition, none of the other cytokines tested, such as IL 1, IL 2, interferons or tumor necrosis factor can express HCS activity. This expression seems to be a specific property of IL 3 and GM-CSF.

Animals↗

[Demonstration of synergy between the factor stimulating granulocytes and macrophages colonies and interleukin-I for the stimulation of prostaglandin E2 synthesis by bone marrow cells].

Conditioned medium from P388 D1 cell line containing interleukin 1 (IL-1) and granulocyte macrophage colony stimulating factor (GM-CSF) can stimulate prostaglandin E2 (PGE2) production by murine bone marrow cells. In this work, we show that although GM-CSF (either purified from P388 D1 CM or murine recombinant GM-CSF) does not significantly alter bone marrow cell PGE2 production, its presence in P388 D1 CM is however necessary to induce this effect since the presence of anti GM-CSF antiserum completely abrogated the increase in PGE2 production in response to P388 D1 CM. In addition IL-1 tested alone does not not modify PGE2 release by bone marrow cells. However, the simultaneous addition of IL-1 and GM-CSF markedly increases PGE2 production. Thus, the ability of P388 D1 CM to stimulate PGE2 synthesis by bone marrow cells appears to result from a synergistic action between GM-CSF and IL-1.

Animals↗

Histamine-producing cell stimulating factor (HCSF) and interleukin 3 (IL 3): evidence for two distinct molecular entities.

Because homogeneously purified interleukin 3 (IL 3) can induce an increase in histamine synthesis by normal bone marrow cells like histamine-producing cell stimulating Factor (HCSF), it has been suggested that HCSF and IL 3 might be identical. In this paper, we provide evidence that HCSF activity can be obtained without IL 3 activity (determined by the proliferation of an IL 3-dependent cell line). This distinction between HCSF and IL 3 has been achieved in three different ways: a) biochemical separation of HCSF from IL 3 in crude secondary MLC supernatants with description of different physicochemical characteristics of the two molecules; b) demonstration of an HCSF activity devoid of IL 3 activity in P388D1 conditioned medium, with the same characteristics as HCSF produced during secondary MLC but different from WEHI-3-derived HCSF activity resulting from IL 3; c) demonstration of a lack of inhibition of HCSF-induced histamine synthesis by anti-IL 3 immunoglobulins that clearly diminish IL 3-induced histamine production. These results demonstrate that two distinct factors (IL 3 and HCSF) promote histamine synthesis, but that IL 3 has more general effects on hemopoietic cells, whereas HCSF seems to be restricted to histamine-producing cells.

Animals↗

Activation of macrophages.

The role of macrophages is essential in the development of a normal immune response. Not only are these cells involved in the initiation of this response by presenting antigens to lymphocytes and by producing Interleukin I, but they also participate in the various phenomena of cellular co-operation and regulation. It is also evident that macrophages can act as cytotoxic effector cells, especially against micro-organisms and tumor cells. This last function is restricted to activated macrophages. The aim of this review is to summarize our present knowledge concerning this "macrophage activation".

Animals↗

[Is the histamine-producing cell stimulating factor (HCSF) identical to interleukin 3 (IL-3)?].

Since homogeneously purified Interleukin 3 can induce an increase in histamine synthesis by normal bone marrow cells (HCSF activity), it has been suggested that HCSF and IL3 could be identical. In this paper, we show evidence that HCSF activity can be obtained without any IL3 activity (determined by the proliferation of an IL3-dependent cell line). This distinction has been achieved in two different ways: (a) the physico-chemical separation of HCSF and IL3 from crude secondary MLC supernatants and (b) the spontaneous production by the P388D1 cell line of a factor possessing all the characteristics of HCSF without any IL3 activity. In addition, preliminary results show that anti-IL3 antibodies do not inhibit the increase in histamine synthesis induced by HCSF while it strongly diminishes that induced by IL3.

Animals↗

Homogeneous interleukin 3 enhances arginase activity in murine hematopoietic cells.

Incubation of murine spleen and bone marrow cells with homogeneously purified interleukin 3 (IL-3) results in increased urea and ornithine production. This phenomenon is explained by a marked enhancement of arginase activity, assessed by transformation of labeled arginine into labeled urea during culture and by intracellular arginase assay. The enhancement of enzymatic activity is evident after 12 hours of incubation with IL-3, reaching a maximum after 24 hours. It is (1) dose dependent, (2) restricted to cells from hematopoietic organs (i.e., spleen and bone marrow), and (3) independent of cell proliferation, since irradiation of bone marrow cells does not abolish the arginase enhancing effect of IL-3 in spite of complete inhibition of proliferation. Furthermore, this new activity is specific to IL-3, since other colony-stimulating factors, i.e., granulocyte-macrophage colony-stimulating factor (GM-CSF) and L cell-derived colony-stimulating factor (L-CSF), do not induce it.

Animals↗

Gut mucosal mast cells. Origin, traffic, and differentiation.

Gut mucosal mast cells (MMC), which are nearly absent in normal mice are abundant during nematode infection. In normal mice, study of MMC precursors (MMC-P: cells giving rise to MMC colonies in the presence of IL-3) show that: (a) their frequency, judged by limiting dilution is very high in bone marrow (BM) and gut, and very low in most lymphoid organs and thoracic duct lymph (TDL); (b) gut MMC-P are Thy-1- Lyt-1-2- and are not rapidly replicating; (c) they are the progeny of less differentiated BM MMC-P which are attracted from the blood to the gut mucosa by local factor(s), other than antigen and T cell factors (since normal amounts of gut MMC-P are found in germ-free, nude, and newborn mice). In mice bearing the Wehi 3 tumor (which releases enough IL-3 to produce detectable blood levels) spleen and mesenteric lymph nodes (LN) show increased MMC-P frequency, the greatest increase being in the gut and BM, where numerous differentiated MMC are found. In Nippostrongylus brasiliensis (Nb)-infested mice (known to develop a large, T cell-dependent, gut MMC infiltration), gut MMC-P proliferation is induced by IL-3 released from gut mucosal Thy-1+ Lyt-2- cells, whose in vitro IL-3 release capability is much higher than that of similar cells from normal mice. Both Nb-stimulated T blasts and proliferating MMC-P undergo cyclic traffic, migrating into the TDL and then seeding the whole length of the gut (a process which allows a widespread immune defense after a local antigenic stimulus). Experiments using 2-d interruption of this traffic and fetal gut grafts, suggest that the continuous homing of T blasts back to the gut which leads to permanent Nb-stimulated IL-3 release, is essential for the full maturation of MMC. Transfer experiments in the rat show that TDL circulating MMC-P rapidly mature into MMC when they home back to the Nb-infested gut. It is proposed that gut MMC arise after several stages of progressive differentiation of MMC-P, influenced both by IL-3 and unidentified gut factor(s).

Animals↗

Ultrastructural study on long-term cultures of bone marrow cells with histamine-producing stimulating factor (HCSF).

In a previous study (Dy et al. 1981) we have demonstrated that histamine-producing cell stimulating factor (HCSF), a lymphokine released by T-cells, is present in supernatants obtained from secondary mixed lymphocyte cultures set up with cells from the donor and the recipient of a skin allograft, and that HCSF causes an increased production of histamine from target cells present in bone marrow. The most abundant source of target cells was found in the less dense layer of a discontinuous Ficoll gradient of bone marrow cells. Ultrastructural studies of this layer showed that it is composed of four types of cell: type I, immature cells; type II, mastocyte-like cells; type III, macrophages and type IV, lymphocytes. We have examined the effect of HCSF on this cell population; in long-term cultures we observed a progressive numerical decrease in type I cells, accompanied by an increase in type II cells (clearly observed as early as 48 h), leading to a pure population of mastocytes cells after 45 days of culture.

Animals↗

In vitro and in vivo histamine-producing cell-stimulating factor (or IL3) production during Nippostrongylus brasiliensis infection: coincidence with self-cure phenomenon.

Spleen cells from Nippostrongylus brasiliensis-infected mice produce large amounts of histamine in response to adult worm antigen. This phenomenon results from the production of HCSF (histamine-producing cell-stimulating factor, probably related to IL3) by sensitized lymphocytes. This factor acts on its target cells (presumably mast cell precursors) by inducing a rapid increase in histamine synthesis. Similarly, parasite infection generates enhanced histamine production by spleen cells in response to concanavalin A (Con A). This results from increases in both HCSF production and the HCSF sensitivity of its target cells. In all cases, maximal histamine and HCSF productions are obtained on day 8 after infection and coincide with parasite rejection. Methyl prednisolone suppresses HCSF production by infected mouse spleen cells in response to worm antigen or Con A. HCSF activity is found in vivo on day 8 in the sera of infected mice, 4 h after they are challenged with an i.v. injection of adult worm antigen. No activity is detected in the sera of normal mice with or without antigen injection. Sera from infected mice that did not receive the antigen exhibit a slight HCSF activity on day 8. Our data bring the first evidence of the existence of an in vivo production of HCSF.

Animals↗

Demonstration of a concanavalin A-induced lymphokine enhancing arginase activity. Effect of presensitization by a skin allograft.

In response to concanavalin A (Con A) mouse spleen cells produce increased amounts of urea. This increase results from arginase activity degrading arginine into urea and ornithine. It is mediated by a soluble protein factor, characterized by its heat stability (10 min at 80 degrees C) and a molecular weight of approximately 32 000. The factor is produced by T cells and acts on a cell population mainly present in bone marrow and spleen. Splenocytes collected from skin allograft recipients during rejection produce more urea in response to Con A than those obtained from normal or syngeneically grafted mice. The maximum urea increase is observed just before and maintained during rejection, declining rapidly thereafter. This phenomenon is explained (a) by a 10-15-fold increase in arginase-enhancing factor production by Con A-stimulated allograft recipient spleen cells and (b) by an increased responsiveness of these splenocytes to the lymphokine.

Animals↗

Evidence for a lymphokine enhancing arginase activity during allograft rejection.

The production of urea and ornithine is increased greatly in spleen cell cultures of an allograft recipient in the presence of donor cells (secondary MLC) in comparison to that of primary MLC (without previous allograft). This phenomenon appears after 24 hr of culture and reaches its maximum at 48 hr. The greatest increase in urea production is observed when the recipient spleen cells are collected at the time of allograft rejection. To obtain this extra production of urea, the stimulating cells in MLC should specifically be of the donor type or at least bear one homology with donor cells at the K or D locus. The increased production of urea and ornithine during MLC results from the action of a lymphokine released by recipient cells in the presence of donor cells. This factor acts upon cells present in bone marrow, spleen, and elicited peritoneal cells but is absent or is present in smaller quantities in thymus and lymph node cells. Target cells of this factor possess numerous macrophage features and could be immature cells of the macrophage line. The lymphokine responsible for this phenomenon is heat-stable, destroyed by trypsin, chymotrypsin, and neuraminidase, and has a m.w. around 32,000. It acts upon its target cells by increasing arginase activity, which results in the production of a large amount of ornithine, an important precursor of polyamine biosynthesis.

Amino Acids↗

Skin allografts generate an enhanced production of histamine and histamine-producing cell-stimulating factor (HCSF) by spleen cells in response to T cell mitogens.

In response to T cell mitogens, spleen cells produce a large amount of histamine, whereas no or a slight increase is observed after B cell mitogen stimulation. This increased histamine production results from the effect of a factor having all the characteristics of HCSF (histamine-producing cell-stimulating factor) already described in secondary MLC supernatant. This factor is produced by Thy-1, 2, Lyt-1, 2-positive cells. Spleen cell cultures derived from skin-allografted mice during rejection produce more histamine in response to T cell mitogens than do spleen cells from normal or syngeneic grafted mice. Such a phenomenon is not observed in response to B cell mitogens. A striking association is found between enhanced histamine synthesis and skin allograft rejection. This phenomenon results from a) a five to 10-fold increase in HCSF production by allograft recipient spleen cells in response to T cell mitogens, and b) an increase in HCSF sensitivity of these spleen cells.

Animals↗